Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

JNM Podcast

Health & Fitness

Activity Overview

Episode publication activity over the past year

Episodes

Should Nuclear Medicine Be An Independent Department?

24 Mar 2026

Contributed by Lukas

Nuclear medicine is uniquely positioned at the intersection of diagnostics and therapeutics, so should it remain housed with imaging modalities, or st...

Bridging Gaps for Radioligand Therapy: Policy Priorities for Scaled Implementation

25 Feb 2026

Contributed by Lukas

A popular saying in the nuclear medicine field is that our work spans "from bench to bedside." But the path to get there isn't always c...

2025: A Year in Review

31 Dec 2025

Contributed by Lukas

Before we pop the champagne and count down to 2026, let’s take one last look back at 2025 through our favorite moments in nuclear medicine. Join hos...

SPARC: Overarching Framework for PSMA PET Reporting

16 Dec 2025

Contributed by Lukas

Data tells us that nuclear medicine has made extraordinary strides in curing prostate cancer, especially with the use of PSMA PET. But how are we repo...

PET-Guided Radiotherapy: Reflections?

20 Nov 2025

Contributed by Lukas

Being able to personalize a patient's treatment is one of the cornerstones of nuclear medicine, but how are we able to do that? PET-Guided radiot...

Biomarkers in Prostate Cancer: What's in the Blood?

25 Sep 2025

Contributed by Lukas

Biomarkers: what are they and how are they useful in the diagnosis and treatment of prostate cancer? On this episode of the JNM Podcast, our panel of ...

From Isotope to Impact: 211At

22 Aug 2025

Contributed by Lukas

Is it really happening? Astatine-211 is a promising new radionuclide being further developed and researched for the treatment of cancer. It is a short...

Live from New Orleans: JNM Podcast with Johannes Czernin and Anna Karmann

06 Aug 2025

Contributed by Lukas

In this live episode of The JNM Podcast, Johannes Czernin interviews Anna Karmann to talk about the various career trajectories available in nuclear m...

Live from New Orleans: JNM Podcast with David Mankoff, Hossein Jadvar, and Todd Peterson

30 Jul 2025

Contributed by Lukas

The JNM Podcast is back and live from New Orleans. Guests David Mankoff, Hossein Jadvar, and Todd Peterson answer the question: "Can society-base...

Live from New Orleans: JNM Podcast with Richard Wahl

16 Jul 2025

Contributed by Lukas

You love the column, now hear it in person! Throughout the meeting, JNM Editor in Chief Johannes Czernin will host Discussions with Leaders to talk ab...

Understanding Metabolic PET Markers Beyond SUV

21 Apr 2025

Contributed by Lukas

Standardized uptake values (SUV) measure a patient's response to nuclear medicine therapy. But what other markers of success are there, and do th...

PSMA PET: From Adolescence to Adulthood

03 Mar 2025

Contributed by Lukas

Is PSMA becoming so regularly used that it's...boring? Not according to this lively discussion. Join us for episode 9 of the JNM Podcast, where h...

Revolutionizing Cardiovascular Imaging with Flurpiridaz

10 Feb 2025

Contributed by Lukas

The JNM Podcast is back in 2025! Join Ken Herrmann, MD, and co-moderator Frank Bengel, MD, for an episode on cardiovascular perfusion imaging. In the ...

Social Media in (Nuclear) Medicine

03 Dec 2024

Contributed by Lukas

Get ready for an episode that's a bit...meta. In Episode 7, our host Ken Herrmann is joined by the podcasters behind GU Cast: Declan Murphy, FRAC...

Bringing PRRT to First Line: NETTER-2

24 Oct 2024

Contributed by Lukas

Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2. NETTER...

Healthcare Systems Readiness: What is Limiting the RLT Scale-up?

28 Aug 2024

Contributed by Lukas

Radioligand therapy (RLT) targets cancer cells with radiation while minimizing impact on surrounding healthy tissue. In this episode of JNM Podcast, o...

The Standard of Care for Metastatic Prostate Cancer

17 Jul 2024

Contributed by Lukas

The VISION Trial is the first-in-its-field study to use radiopharmaceuticals that directly target prostate cancer tumors. Hear from one of the lead re...

Alpha is More Than Just Ac-225: Pb-212

03 Jun 2024

Contributed by Lukas

This month's episode of the JNM Podcast takes the discussion of Pb-212 worldwide! Researchers from the UK, Australia, and North America discuss t...

Advances in Dementia Imaging: Insights from Experts

03 Jun 2024

Contributed by Lukas

The Journal of Nuclear Medicine presents a new podcast on advances in dementia imaging. Panelists discuss the importance of amyloid and tau PET imagin...

The Future of FAPI Therapy

03 Jun 2024

Contributed by Lukas

The Journal of Nuclear Medicine presents a new podcast on FAPI-directed theranostics for cancer diagnosis and treatment. Join moderator Ken Herrmann (...